Financial statements Gel-Lab
Balance sheet data of GEL-LAB
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 47 286,64 | 82 175,27 | 149 900,45 |
A. Fixed assets | 0,00 | 31 286,63 | 11 526,59 |
B. Current assets | 47 286,64 | 50 888,64 | 138 373,86 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
Total liabilities | 47 286,64 | 82 175,27 | 149 900,45 |
A. Equity | -14 143,93 | -38 496,12 | -92 277,06 |
B. Liabilities and provisions for liabilities | 61 430,57 | 120 671,39 | 242 177,51 |
I. Long-term liabilities | - | - | - |
II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.